JRCT ID: jRCT2080220434
Registered date:03/09/2007
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Primary osteoporosis |
Date of first enrollment | 03/09/2007 |
Target sample size | 500 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : MN-10-T INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Injection |
Outcome(s)
Primary Outcome | Incidence of new vertebral fractures |
---|---|
Secondary Outcome | Percent changes in the lumbar spine bone mineral density |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | -Patients with prevalent fragile vertebral fractures -Patients who have low bone mineral density |
Exclude criteria | Patient who have a metabolic bone disorder other than osteoporosis |
Related Information
Primary Sponsor | ASAHI KASEI PHARMA CORPORATION |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-070444 |
Contact
Public contact | |
Name | |
Address | ct-info@om.asahi-kasei.co.jp |
Telephone | |
Affiliation | Asahi Kasei Pharma Corporation |
Scientific contact | |
Name | |
Address | ct-info@om.asahi-kasei.co.jp |
Telephone | |
Affiliation | Asahi Kasei Pharma Corporation |